Cannabis
Green Mountain Receives Cannabis Cultivation License from Health Canada
Penticton, British Columbia–(Newsfile Corp. – January 31, 2022) – Green Mountain Health Alliance Ltd. (the “Company” or “Green Mountain”), is pleased to announce a major landmark upon receiving its cannabis cultivation and medical sales license from Health Canada.
“Obtaining a standard cultivation license represents a significant milestone for the business” said Green Mountain President & CEO, Wade Attwood. “This is the game-changer that opens the door to production and cash-flow. We’ve been preparing for this moment for some time now and we have already pre-sold our entire greenhouse space, half under contract for 12 months and the other half for 24 months. This is extraordinary by any measure and testament to the strength of the Green Mountain team. We expect to be in production within a couple of weeks and you will be able to follow our progress via our social media outlets. We continue to raise funds so that we can expedite the construction of phase 2 of our expansion plan and maximize our gross revenues.”
As a License Holder, the Company will be able to capitalize on the initiatives it has been developing since inception, including:
- Wholly owned online medical cannabis consulting platform Greener Life Medical (GLM). GLM is based out of Toronto with national coverage. GLM currently oversees over 400 medical patients.
- A symbiotic relationship with the investment arm of Canada’s largest Indigenous community representing a rare win-win for consumers and shareholders.
- Local retail opportunities in the Okanagan for high-end organic craft cannabis products.
- Development of cannabis derived pharmaceutical products via research and clinical trials with Sunnybrook Hospital (fully affiliated with the University of Toronto).
- Wholesale flower and oil opportunities allowing the business to get traction from the first crop onwards.
“Thanks to our shareholders for their ongoing support. We look forward to growing the best organic cannabis possible and fulfilling the presold contracts we have in hand with leading national brands.” – Wade Attwood, Green Mountain President & CEO.
This update contains forward-looking statements, which include, but are not limited to, statements concerning Green Mountain Health Alliance Ltd. and our plans and projections. You should not rely upon forward-looking statements as predictions of future events. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, as more fully described in our filings on SEDAR.com. In light of such risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.
For more information about Green Mountain, please contact:
Wade Attwood
President
[email protected]
For investor inquiries:
Michele Lise
Investor Relations
[email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/112114
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE4 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis3 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt3 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace